Activating germ-line point mutations in the RET receptor are responsible for multiple endocrine neoplasia type 2-associated MTC, whereas somatic RET rearrangements are prevalent in PTC [5]. This evidence concerns the gene RET and multiple endocrine neoplasia type 2.